Sherrington Robin, EVP, Strategy & Innovation at Xenon Pharmaceuticals Inc. (XENE), sold 16,350 shares at $18.81 ($308K) on 2021-05-28, disclosed to the SEC on 2021-06-01.
Open-market sale of $308k XENE by EVP, Strategy & Innovation. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.81 | 2,912 | $55K | 17.8% |
| 2 | $18.81 | 2,912 | $55K | 17.8% |
| 3 | $18.81 | 3,155 | $59K | 19.3% |
| 4 | $18.81 | 3,155 | $59K | 19.3% |
| 5 | $18.91 | 2,024 | $38K | 12.4% |
| 6 | $18.91 | 2,192 |
| $41K |
| 13.5% |
| Total | $18.84 avg | 16,350 | $308K | 100% |
| Filing → |
| XENE | SELL | 2022-03-08 | $867K | — | Filing → |